BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26921839)

  • 21. The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
    Shani S; Yahalom Z
    Food Drug Law J; 2008; 63(3):701-11. PubMed ID: 19031669
    [No Abstract]   [Full Text] [Related]  

  • 22. Regulatory toxicity testing and the Animals (Scientific Procedures) Act 1986: response of the Home Secretary to the recommendations in the Animal Procedures Committee's Report on Regulatory Toxicity.
    ;
    Altern Lab Anim; 1996; 24(1):111-7. PubMed ID: 11660210
    [No Abstract]   [Full Text] [Related]  

  • 23. The business of human embryonic stem cell research and an international analysis of relevant laws.
    De Trizio E; Brennan CS
    J Biolaw Bus; 2004; 7(4):14-22. PubMed ID: 15675095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Legal and regulatory news from Europe.
    Hitchcock J
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():44-6. PubMed ID: 25457961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fraudsters operate and officialdom turns a blind eye: a proposal for controlling stem cell therapy in China.
    Jiang L; Dong BH
    Med Health Care Philos; 2016 Sep; 19(3):403-10. PubMed ID: 26906907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A few ethical issues in translational research for gene and cell therapy.
    Riva L; Petrini C
    J Transl Med; 2019 Nov; 17(1):395. PubMed ID: 31779636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical considerations in European cross-national research.
    Taylor MF
    Int Soc Sci J; 1994 Dec; 46(4):523-32. PubMed ID: 11660701
    [No Abstract]   [Full Text] [Related]  

  • 28. New regulation for clinical stem cell research in China: expected impact and challenges for implementation.
    Rosemann A; Sleeboom-Faulkner M
    Regen Med; 2016 Jan; 11(1):5-9. PubMed ID: 26680327
    [No Abstract]   [Full Text] [Related]  

  • 29. Cell Churches and Stem Cell Marketing in South Korea and the United States.
    Sipp D
    Dev World Bioeth; 2017 Dec; 17(3):167-172. PubMed ID: 27214044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International regulatory aspects of clinical periodontal research.
    Cooley WE; Castellion AW
    Ann Periodontol; 1997 Mar; 2(1):18-30. PubMed ID: 9151540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International harmonization of models for selecting less toxic chemical alternatives: Effect of regulatory disparities in the United States and Europe.
    Lam CW; Aguirre MP; Schischke K; Nissen NF; Ogunseitan OA; Schoenung JM
    Integr Environ Assess Manag; 2012 Oct; 8(4):723-30. PubMed ID: 22492719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New developments in international nursing ethics.
    Davis AJ
    Nurs Clin North Am; 1989 Jun; 24(2):571-7. PubMed ID: 2726578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell research: Regulating translational application.
    Nat Cell Biol; 2012 May; 14(6):557. PubMed ID: 22643872
    [No Abstract]   [Full Text] [Related]  

  • 34. Trials on trial.
    Wuethrich B
    New Sci; 1994 May; 142(1927):14-5. PubMed ID: 11656346
    [No Abstract]   [Full Text] [Related]  

  • 35. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
    Salmikangas P; Schuessler-Lenz M; Ruiz S; Celis P; Reischl I; Menezes-Ferreira M; Flory E; Renner M; Ferry N
    Adv Exp Med Biol; 2015; 871():103-30. PubMed ID: 26374215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changing landscape of European and international regulation on embryonic stem cell research.
    Elstner A; Damaschun A; Kurtz A; Stacey G; ArĂ¡n B; Veiga A; Borstlap J
    Stem Cell Res; 2009 Mar; 2(2):101-7. PubMed ID: 19383415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research ethics review in Australia, Europe and North America.
    McNeill PM
    IRB; 1989; 11(3):4-7. PubMed ID: 11650207
    [No Abstract]   [Full Text] [Related]  

  • 38. Overview of regulation of gene therapy in Europe: a current statement including reference to US regulation.
    Cohen-Haguenauer O
    Hum Gene Ther; 1995 Jun; 6(6):773-85. PubMed ID: 7548277
    [No Abstract]   [Full Text] [Related]  

  • 39. Cross-border assisted reproduction care in Asia: implications for access, equity and regulations.
    Whittaker A
    Reprod Health Matters; 2011 May; 19(37):107-16. PubMed ID: 21555091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pluralization of the international: Resistance and alter-standardization in regenerative stem cell medicine.
    Rosemann A; Chaisinthop N
    Soc Stud Sci; 2016 Feb; 46(1):112-39. PubMed ID: 26983174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.